Home › Companies › JAZZ PHARMACEUTICALS PLC › 2023-2024

JAZZ PHARMACEUTICALS PLC 2023-2024 Proxy Voting Records

Compiled from SEC Form N-PX filings. Page generated October 14, 2026.

  • 13Reported items
  • 540Asset managers
  • 4,910Fund votes
  • August 3, 2023Meeting date

Results at a glance

No official results are on file for this meeting: no Form 8-K tally (Item 5.07) from JAZZ PHARMACEUTICALS PLC has been matched to it. The figures below are the funds’ own votes from Form N-PX. They are not the meeting result, so they are not used to judge dissent.

Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided

Proxy season: 2023-2024 2024-2025 2025-2026

Explore JAZZ PHARMACEUTICALS PLC in the interactive database Compare manager voting policies

How asset managers voted at the JAZZ PHARMACEUTICALS PLC 2023-2024 meeting

Each item below shows how the 540 asset managers that disclosed a JAZZ PHARMACEUTICALS PLC vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of JAZZ PHARMACEUTICALS PLC’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. To elect four nominees for director named below to hold office until the 2026 Annual General Meeting…: Anne O'Riordan

No official resultsDIRECTOR ELECTIONS

Combines 9 wordings of this item as funds reported it.

99.2% of fund votes cast · no official result

FOR
Details: description as filed, votes by 129 asset managers

Description as filed by funds: To elect four nominees for director named below to hold office until the 2026 Annual General Meeting of Shareholders: Anne O'Riordan

The 129 asset managers below reported 22,418,993 for, 170,413 against, 25,047 abstained. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 22,418,993AGAINST: 170,413ABSTAIN: 25,047
Largest asset managers voting on “To elect four nominees for director named below to hold office until the 2026 Annual General Meeting of Shareh” at JAZZ PHARMACEUTICALS PLC, 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard6,038,8230 00For
BlackRock3,454,8540 00For
Fidelity1,937,7110 00For
JPMorgan1,487,7350 00For
Hartford1,008,2930 00For
Columbia Threadneedle976,7450 00For
Dimensional612,8170 00For
Pacer Funds Trust489,6820 00For
FRANKLIN STRATEGIC SERIES461,9630 00For
Prudential/PGIM460,7520 00For
Charles Schwab456,9650 00For
Pear Tree Funds416,7000 00For
State Street392,3740 00For
Jackson National263,1300 00For
TIAA255,2510 00For
JANUS INVESTMENT FUND247,2910 00For
John Hancock218,6800 00For
Invesco217,4600 00For
SEI199,7960 00For
Russell Investments192,2360 00For
Bridge Builder Trust179,7170 00For
AIG/SunAmerica150,5780 00For
Franklin Custodian Funds150,0000 00For
Northwestern Mutual144,8180 00For
Equitable123,2170 00For

Showing the 25 largest of 129 asset managers. See all 129 in the interactive database.

2. To elect four nominees for director named below to hold office until the 2026 Annual General Meeting…: Bruce C. Cozadd

No official resultsDIRECTOR ELECTIONS

Combines 8 wordings of this item as funds reported it.

99.7% of fund votes cast · no official result

FOR
Details: description as filed, votes by 129 asset managers

Description as filed by funds: To elect four nominees for director named below to hold office until the 2026 Annual General Meeting of Shareholders: Bruce C. Cozadd

The 129 asset managers below reported 22,534,687 for, 54,719 against, 25,047 abstained. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 22,534,687AGAINST: 54,719ABSTAIN: 25,047
Largest asset managers voting on “To elect four nominees for director named below to hold office until the 2026 Annual General Meeting of Shareh” at JAZZ PHARMACEUTICALS PLC, 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard6,038,8230 00For
BlackRock3,454,8540 00For
Fidelity1,937,7110 00For
JPMorgan1,487,7350 00For
Hartford1,008,2930 00For
Columbia Threadneedle976,7450 00For
Dimensional612,8170 00For
Pacer Funds Trust489,6820 00For
FRANKLIN STRATEGIC SERIES461,9630 00For
Prudential/PGIM460,7520 00For
Charles Schwab456,9650 00For
Pear Tree Funds416,7000 00For
State Street392,3740 00For
Jackson National263,1300 00For
TIAA255,2510 00For
JANUS INVESTMENT FUND247,2910 00For
John Hancock218,6800 00For
Invesco217,4600 00For
SEI199,7960 00For
Russell Investments192,2360 00For
Bridge Builder Trust175,0884,629 00For
AIG/SunAmerica150,5780 00For
Franklin Custodian Funds150,0000 00For
Northwestern Mutual144,8180 00For
Equitable123,2170 00For

Showing the 25 largest of 129 asset managers. See all 129 in the interactive database.

3. To elect four nominees for director named below to hold office until the 2026 Annual General…: Heather Ann McSharry

No official resultsDIRECTOR ELECTIONS

Combines 8 wordings of this item as funds reported it.

96% of fund votes cast · no official result

FOR
Details: description as filed, votes by 129 asset managers

Description as filed by funds: To elect four nominees for director named below to hold office until the 2026 Annual General Meeting of Shareholders: Heather Ann McSharry

The 129 asset managers below reported 21,725,733 for, 863,673 against, 25,047 abstained. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 21,725,733AGAINST: 863,673ABSTAIN: 25,047
Largest asset managers voting on “To elect four nominees for director named below to hold office until the 2026 Annual General Meeting of Shareh” at JAZZ PHARMACEUTICALS PLC, 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard6,038,8230 00For
BlackRock3,454,8540 00For
Fidelity1,937,7110 00For
JPMorgan1,487,7350 00For
Hartford1,008,2930 00For
Columbia Threadneedle976,7450 00For
Dimensional612,8170 00For
Pacer Funds Trust489,6820 00For
FRANKLIN STRATEGIC SERIES461,9630 00For
Prudential/PGIM460,7520 00For
Charles Schwab456,9650 00For
Pear Tree Funds416,7000 00For
State Street392,3740 00For
Jackson National263,1300 00For
TIAA0255,251 00Against
JANUS INVESTMENT FUND247,2910 00For
John Hancock218,6800 00For
Invesco0217,460 00Against
SEI199,7960 00For
Russell Investments192,2360 00For
Bridge Builder Trust179,7170 00For
AIG/SunAmerica150,5780 00For
Franklin Custodian Funds150,0000 00For
Northwestern Mutual144,8180 00For
Equitable36,76486,453 00Mixed

Showing the 25 largest of 129 asset managers. See all 129 in the interactive database.

4. To elect four nominees for director named below to hold office until the 2026 Annual General…: Rick E. Winningham

No official resultsDIRECTOR ELECTIONS

Combines 8 wordings of this item as funds reported it.

99.1% of fund votes cast · no official result

FOR
Details: description as filed, votes by 129 asset managers

Description as filed by funds: To elect four nominees for director named below to hold office until the 2026 Annual General Meeting of Shareholders: Rick E. Winningham

The 129 asset managers below reported 22,406,041 for, 183,365 against, 25,047 abstained. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 22,406,041AGAINST: 183,365ABSTAIN: 25,047
Largest asset managers voting on “To elect four nominees for director named below to hold office until the 2026 Annual General Meeting of Shareh” at JAZZ PHARMACEUTICALS PLC, 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard6,038,8230 00For
BlackRock3,454,8540 00For
Fidelity1,937,7110 00For
JPMorgan1,487,7350 00For
Hartford1,008,2930 00For
Columbia Threadneedle976,7450 00For
Dimensional612,8170 00For
Pacer Funds Trust489,6820 00For
FRANKLIN STRATEGIC SERIES461,9630 00For
Prudential/PGIM460,7520 00For
Charles Schwab456,9650 00For
Pear Tree Funds416,7000 00For
State Street392,3740 00For
Jackson National263,1300 00For
TIAA255,2510 00For
JANUS INVESTMENT FUND247,2910 00For
John Hancock218,6800 00For
Invesco217,4600 00For
SEI199,7960 00For
Russell Investments192,2360 00For
Bridge Builder Trust175,0884,629 00For
AIG/SunAmerica150,5780 00For
Franklin Custodian Funds150,0000 00For
Northwestern Mutual144,8180 00For
Equitable123,2170 00For

Showing the 25 largest of 129 asset managers. See all 129 in the interactive database.

5. To grant the Board of Directors authority under Irish law to allot and issue ordinary shares for cash without first…

No official resultsCAPITAL STRUCTURE

Combines 5 wordings of this item as funds reported it.

95% of fund votes cast · no official result

FOR
Details: description as filed, votes by 126 asset managers

Description as filed by funds: To grant the Board of Directors authority under Irish law to allot and issue ordinary shares for cash without first offering those ordinary shares to existing shareholders pursuant to the statutory pre- emption right that would otherwise apply.

The 126 asset managers below reported 21,530,185 for, 1,025,609 against, 14,025 abstained. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 21,530,185AGAINST: 1,025,609ABSTAIN: 14,025
Largest asset managers voting on “To grant the Board of Directors authority under Irish law to allot and issue ordinary shares for cash without ” at JAZZ PHARMACEUTICALS PLC, 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard6,038,8230 00For
BlackRock3,454,8540 00For
Fidelity1,937,7110 00For
JPMorgan1,487,7350 00For
Hartford1,008,2930 00For
Columbia Threadneedle0976,745 00Against
Dimensional612,8170 00For
Pacer Funds Trust489,6820 00For
FRANKLIN STRATEGIC SERIES461,9630 00For
Prudential/PGIM460,7520 00For
Charles Schwab456,9650 00For
Pear Tree Funds416,7000 00For
State Street392,3740 00For
Jackson National263,1300 00For
TIAA255,2510 00For
JANUS INVESTMENT FUND247,2910 00For
John Hancock218,6800 00For
Invesco217,4600 00For
SEI199,7960 00For
Russell Investments192,2360 00For
Bridge Builder Trust175,0884,629 00For
AIG/SunAmerica150,5780 00For
Franklin Custodian Funds150,0000 00For
Northwestern Mutual144,8180 00For
Equitable123,2170 00For

Showing the 25 largest of 126 asset managers. See all 126 in the interactive database.

6. Authorise Issue of Equity without Pre-emptive Rights

No official resultsCAPITAL STRUCTURE

100% of fund votes cast · no official result

FOR
Details: votes by 2 asset managers

The 2 asset managers below reported 39,850 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 39,850
Largest asset managers voting on “Authorise Issue of Equity without Pre-emptive Rights” at JAZZ PHARMACEUTICALS PLC, 2023-2024
Asset managerForAgainst AbstainWithheldVote
Empower37,9590 00For
Advisors' Inner Circle Fund III1,8910 00For

7. To approve any motion to adjourn the Annual General Meeting, or any adjournments thereof, to another time and place to…

No official resultsCORPORATE GOVERNANCE

Combines 5 wordings of this item as funds reported it.

98% of fund votes cast · no official result

FOR
Details: description as filed, votes by 127 asset managers

Description as filed by funds: To approve any motion to adjourn the Annual General Meeting, or any adjournments thereof, to another time and place to solicit additional proxies if there are insufficient votes at the time of the Annual General Meeting to approve Proposal 4.

The 127 asset managers below reported 22,104,184 for, 445,278 against, 25,047 abstained. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 22,104,184AGAINST: 445,278ABSTAIN: 25,047
Largest asset managers voting on “To approve any motion to adjourn the Annual General Meeting, or any adjournments thereof, to another time and ” at JAZZ PHARMACEUTICALS PLC, 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard6,038,8230 00For
BlackRock3,454,8540 00For
Fidelity1,937,7110 00For
JPMorgan1,487,7350 00For
Hartford1,008,2930 00For
Columbia Threadneedle976,7450 00For
Dimensional612,8170 00For
Pacer Funds Trust489,6820 00For
FRANKLIN STRATEGIC SERIES461,9630 00For
Prudential/PGIM458,3022,450 00For
Charles Schwab456,9650 00For
Pear Tree Funds416,7000 00For
State Street0392,374 00Against
Jackson National263,1300 00For
TIAA255,2510 00For
JANUS INVESTMENT FUND247,2910 00For
John Hancock218,6800 00For
Invesco217,4600 00For
SEI192,4777,319 00For
Russell Investments192,2360 00For
Bridge Builder Trust175,0884,629 00For
AIG/SunAmerica150,5780 00For
Franklin Custodian Funds150,0000 00For
Northwestern Mutual144,8180 00For
Equitable123,2170 00For

Showing the 25 largest of 127 asset managers. See all 127 in the interactive database.

8. Adjourn Meeting

100% of fund votes cast · no official result

FOR
Details: votes by 2 asset managers

The 2 asset managers below reported 39,850 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 39,850
Largest asset managers voting on “Adjourn Meeting” at JAZZ PHARMACEUTICALS PLC, 2023-2024
Asset managerForAgainst AbstainWithheldVote
Empower37,9590 00For
Advisors' Inner Circle Fund III1,8910 00For

9. To approve, on a non-binding advisory basis, the compensation of Jazz Pharmaceuticals plc's named executive officers as…

No official resultsFund totals may overlapSECTION 14A SAY-ON-PAY VOTES

Combines 16 wordings of this item as funds reported it.

94% Fund and manager reports combined; may count the same shares twice · no official result

FOR
Details: description as filed, votes by 503 asset managers

Description as filed by funds: To approve, on a non-binding advisory basis, the compensation of Jazz Pharmaceuticals plc's named executive officers as disclosed in the proxy statement.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Fund voting reports: 123 asset managers voting on “To approve, on a non-binding advisory basis, the compensation of Jazz Pharmaceuticals plc's named executive of” at JAZZ PHARMACEUTICALS PLC, 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard6,038,8230 00For
BlackRock3,454,8540 00For
Fidelity1,937,7110 00For
JPMorgan1,487,7350 00For
Hartford1,008,2930 00For
Columbia Threadneedle976,7450 00For
Dimensional612,8170 00For
Pacer Funds Trust489,6820 00For
FRANKLIN STRATEGIC SERIES461,9630 00For
Prudential/PGIM460,7520 00For
Charles Schwab456,9650 00For
Pear Tree Funds416,7000 00For
State Street392,3740 00For
Jackson National263,1300 00For
TIAA255,2510 00For
JANUS INVESTMENT FUND247,2910 00For
John Hancock218,6800 00For
Invesco217,4600 00For
SEI199,7960 00For
Russell Investments192,2360 00For
Bridge Builder Trust179,7170 00For
AIG/SunAmerica150,5780 00For
Franklin Custodian Funds150,0000 00For
Northwestern Mutual144,8180 00For
Equitable123,2170 00For

Fund voting reports, all 123 managers: 22,541,693 for, 7,762 against, 25,047 abstained. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 413 asset managers voting on “To approve, on a non-binding advisory basis, the compensation of Jazz Pharmaceuticals plc's named executive of” at JAZZ PHARMACEUTICALS PLC, 2023-2024
Asset managerForAgainst AbstainWithheldVote
BlackRock2,843,865501 00For
State Street1,939,0620 00For
LSV ASSET MANAGEMENT1,611,61224,710 00For
Wellington1,521,7310 00For
FRANKLIN ADVISERS INC1,213,8330 00For
Deep Track Capital, LP1,200,0000 00For
Fidelity1,199,2450 00For
Swedbank Robur Fonder AB01,069,994 00Against
GEODE CAPITAL MANAGEMENT, LLC965,1060 00For
SAMLYN CAPITAL, LLC818,3540 00For
BNP Paribas Asset Management Holding S.A.0718,434 00Against
MELLON INVESTMENTS Corp667,2480 00For
Baupost622,6960 00For
Avidity Partners Management LP551,4000 00For
Renaissance478,1170 00For
Charles Schwab459,3010 00For
Polaris Capital Management, LLC432,1600 00For
JENNISON ASSOCIATES LLC422,7310 00For
GW&K Investment Management, LLC371,8720 00For
Nuveen345,4000 00For
BANK OF AMERICA NA327,0080 00For
Redmile Group, LLC315,7590 00For
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP283,89327,048 00Mixed
Brandywine Global Investment Management, LLC304,8200 00For
SEI263,0568,912 00For

Institutional-manager reports, all 413 managers: 26,796,848 for, 3,228,198 against, 6 withheld, 1,466 not voted. Showing the 25 largest; see all in the interactive database.

10. Advisory Vote to Ratify Named Executive Officers' Compensation

No official resultsFund totals may overlapSECTION 14A SAY-ON-PAY VOTES

99% Fund and manager reports combined; may count the same shares twice · no official result

FOR
Details: votes by 17 asset managers

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Fund voting reports: 2 asset managers voting on “Advisory Vote to Ratify Named Executive Officers' Compensation” at JAZZ PHARMACEUTICALS PLC, 2023-2024
Asset managerForAgainst AbstainWithheldVote
Empower37,9590 00For
Advisors' Inner Circle Fund III1,8910 00For

Fund voting reports, all 2 managers: 39,850 for.

Institutional-manager reports: 15 asset managers voting on “Advisory Vote to Ratify Named Executive Officers' Compensation” at JAZZ PHARMACEUTICALS PLC, 2023-2024
Asset managerForAgainst AbstainWithheldVote
JPMorgan1,902,9210 00For
APG Asset Management US Inc.206,4700 00For
Rokos Capital Management LLP183,1090 00For
STOREBRAND ASSET MANAGEMENT AS61,1050 00For
Desjardins Global Asset Management Inc.012,566 00Against
NORDEA INVESTMENT MANAGEMENT AB06,914 00Against
TD ASSET MANAGEMENT INC6,6140 00For
Regime de rentes du Mouvement Desjardins05,836 00Against
OSSIAM2,4330 00For
Qtron Investments LLC1,2500 00For
Echo Street Capital Management LLC1,2450 00For
TOBAM7160 00For
CORNELL UNIVERSITY940 00For
Convergence Investment Partners, LLC470 00For
Edgemoor Investment Advisors, Inc.330 00For

Institutional-manager reports, all 15 managers: 2,366,037 for, 25,316 against.

11. 14A Executive Compensation

No official resultsSECTION 14A SAY-ON-PAY VOTES

100% of fund votes cast · no official result

FOR
Details: votes by 4 asset managers

The 4 asset managers below reported 16,592 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 16,592
Largest asset managers voting on “14A Executive Compensation” at JAZZ PHARMACEUTICALS PLC, 2023-2024
Asset managerForAgainst AbstainWithheldVote
Granite Investment Partners, LLC16,5640 00For
BALLAST ADVISORS LLC220 00For
GRIMES & COMPANY, INC.60 00For
Wallington Asset Management, LLC00 00--

12. To ratify, on a non-binding advisory basis, the appointment of KPMG as the independent auditors of Jazz Pharmaceuticals…

No official resultsAUDIT-RELATED

Combines 6 wordings of this item as funds reported it.

99.9% of fund votes cast · no official result

FOR
Details: description as filed, votes by 127 asset managers

Description as filed by funds: To ratify, on a non-binding advisory basis, the appointment of KPMG as the independent auditors of Jazz Pharmaceuticals plc for the fiscal year ending December 31, 2023 and to authorize, in a binding vote, the Board of Directors, acting through the audit committee, to determine KPMG's remuneration.

The 127 asset managers below reported 22,541,303 for, 8,159 against, 25,047 abstained. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 22,541,303AGAINST: 8,159ABSTAIN: 25,047
Largest asset managers voting on “To ratify, on a non-binding advisory basis, the appointment of KPMG as the independent auditors of Jazz Pharma” at JAZZ PHARMACEUTICALS PLC, 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard6,038,8230 00For
BlackRock3,454,8540 00For
Fidelity1,937,7110 00For
JPMorgan1,487,7350 00For
Hartford1,008,2930 00For
Columbia Threadneedle976,7450 00For
Dimensional612,8170 00For
Pacer Funds Trust489,6820 00For
FRANKLIN STRATEGIC SERIES461,9630 00For
Prudential/PGIM460,7520 00For
Charles Schwab456,9650 00For
Pear Tree Funds416,7000 00For
State Street392,3740 00For
Jackson National263,1300 00For
TIAA255,2510 00For
JANUS INVESTMENT FUND247,2910 00For
John Hancock218,6800 00For
Invesco217,4600 00For
SEI199,7960 00For
Russell Investments192,2360 00For
Bridge Builder Trust179,7170 00For
AIG/SunAmerica150,5780 00For
Franklin Custodian Funds150,0000 00For
Northwestern Mutual144,8180 00For
Equitable123,2170 00For

Showing the 25 largest of 127 asset managers. See all 127 in the interactive database.

13. Approve KPMG as Auditors and Authorize Board to Fix Their Remuneration

No official resultsAUDIT-RELATED

100% of fund votes cast · no official result

FOR
Details: votes by 2 asset managers

The 2 asset managers below reported 39,850 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 39,850
Largest asset managers voting on “Approve KPMG as Auditors and Authorize Board to Fix Their Remuneration” at JAZZ PHARMACEUTICALS PLC, 2023-2024
Asset managerForAgainst AbstainWithheldVote
Empower37,9590 00For
Advisors' Inner Circle Fund III1,8910 00For

Not shown here: this season’s fund filings also report 2 items from the meeting of July 25, 2024, which belongs to the 2024-2025 season. A meeting outside this season’s July 1 to June 30 window is not counted in this page’s items or in its totals of asset managers and fund votes.

Largest JAZZ PHARMACEUTICALS PLC shareholders voting in 2023-2024

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 63,214,000 shares outstanding at the time of that meeting.

Fund voting reports: top JAZZ PHARMACEUTICALS PLC shareholders by shares voted on “To approve, on a non-binding advisory basis, the compensation of Jazz Pharmaceuticals plc's…”, 2023-2024
#Asset manager % of shares outstanding
1Vanguard 9.55%
2BlackRock 5.47%
3Fidelity 3.07%
4JPMorgan 2.35%
5Hartford 1.60%
6Columbia Threadneedle 1.55%
7Dimensional 0.97%
8Pacer Funds Trust 0.77%
9FRANKLIN STRATEGIC SERIES 0.73%
10Prudential/PGIM 0.73%
Institutional-manager reports: top JAZZ PHARMACEUTICALS PLC shareholders by shares voted on “To approve, on a non-binding advisory basis, the compensation of Jazz Pharmaceuticals plc's…”, 2023-2024
#Asset manager % of shares outstanding
1BlackRock 4.50%
2State Street 3.07%
3LSV ASSET MANAGEMENT 2.59%
4Wellington 2.41%
5FRANKLIN ADVISERS INC 1.92%
6Deep Track Capital, LP 1.90%
7Fidelity 1.90%
8Swedbank Robur Fonder AB 1.69%
9GEODE CAPITAL MANAGEMENT, LLC 1.53%
10SAMLYN CAPITAL, LLC 1.29%

Reported JAZZ PHARMACEUTICALS PLC holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.

JAZZ PHARMACEUTICALS PLC holdings and ownership disclosed for the 2023-2024 proxy season
Holder % outstanding Disclosure
Vanguard Group 9.34% 13F
BlackRock 8.79% 13F
State Street 3.89% 13F
JPMorgan Chase 2.95% 13F
Seamus Mulligan 1.90% DEF14A
Renaissance Technologies 1.84% 13F
Geode Capital 1.75% 13F
Franklin Templeton 1.48% 13F
Bruce C. Cozadd 1.42% DEF14A
Dimensional Fund Advisors 1.30% 13F

Percentages above are of 63,214,000 shares outstanding, as reported by JAZZ PHARMACEUTICALS PLC on its Form 10-K dated December 31, 2022 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from JAZZ PHARMACEUTICALS PLC’s 10-K dated December 31, 2022. This page is a static snapshot rebuilt weekly on October 14, 2026; a live search always shows the current data.

At JAZZ PHARMACEUTICALS PLC's shareholder meeting held August 3, 2023, in the 2023-2024 proxy season, 540 asset managers reported how they voted in their SEC Form N-PX filings, covering 4,910 separate fund positions. Their filings are grouped here into 13 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. No official Form 8-K vote tally has been matched to this meeting, so this page states no certified outcome for its most widely held ballot item. On that item — To approve, on a non-binding advisory basis, the compensation of Jazz Pharmaceuticals plc's… — the reporting funds and managers cast 94% of the shares they voted in favour (FOR divided by FOR plus AGAINST plus WITHHELD; abstained and unvoted shares are excluded because neither took a side). Fund and manager reports are combined in it and may count the same shares twice: it adds fund reports to institutional-manager reports, which can cover the same shares. It is not the company's certified result.

JAZZ PHARMACEUTICALS PLC proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.

Download data (CSV): ballot items · votes by manager · column guide.